Department of Nuclear Medicine and Radiology, .
Department of Endocrine Surgery and .
Nucl Med Commun. 2024 Nov 1;45(11):938-946. doi: 10.1097/MNM.0000000000001887. Epub 2024 Aug 5.
18 F-fluorocholine PET/CT is considered the imaging gold standard for detection of hyperfunctioning parathyroid glands . However, increased uptake might also occur in the thyroid gland. The aim of our study was to assess the incidence and significance of 18 F-fluorocholine uptake in the thyroid gland in patients with hyperparathyroidism.
This retrospective study includes 195 consecutive patients with hyperparathyroidism, who underwent 18 F-fluorocholine PET/CT, for detection of hyperfunctioning parathyroid glands. PET/CT images were reviewed by two nuclear medicine physicians for the presence of focal or diffuse thyroid uptake. PET/CT results were compared with laboratory parameters, ultrasonography, EU-TIRADS classification in the presence of thyroid nodules, cytology, and final histology.
25 patients (13%) showed 18 F-fluorocholine uptake in the thyroid gland: focal thyroid uptake (FTU) in 7 patients (4%), diffuse thyroid uptake (DTU) in 8 patients (4%), and combined uptake (FTU + DTU) in 10 patients (5%), with a total of 20 active thyroid nodules. There was no correlation between EU-TIRADS classification and PET parameters. One highly 18 F-fluorocholine active thyroid nodule and one isoactive thyroid nodule turned out to be papillary thyroid cancers in the final histology; 50% of the patients with DTU had Hashimoto's thyroiditis.
Incidental 18 F-fluorocholine uptake in the thyroid gland was observed in 13% of patients. As reported for 18 F-FDG, focal 18 F-fluorocholine uptake might represent thyroid cancer and should be evaluated with ultrasound and, if indicated, with fine-needle aspiration cytology. Diffuse 18 F-fluorocholine uptake most likely represents multinodular goiter or Hashimoto's thyroiditis.
18 F-氟胆碱 PET/CT 被认为是检测功能亢进甲状旁腺的成像金标准。然而,甲状腺也可能出现摄取增加。本研究旨在评估甲状旁腺功能亢进患者甲状腺中 18 F-氟胆碱摄取的发生率和意义。
这项回顾性研究包括 195 例连续的甲状旁腺功能亢进患者,他们接受了 18 F-氟胆碱 PET/CT 检查,以检测功能亢进的甲状旁腺。两名核医学医师对 PET/CT 图像进行了回顾,以评估是否存在局灶性或弥漫性甲状腺摄取。将 PET/CT 结果与实验室参数、超声、存在甲状腺结节时的 EU-TIRADS 分类、细胞学和最终组织学进行比较。
25 例患者(13%)甲状腺出现 18 F-氟胆碱摄取:7 例(4%)为局灶性甲状腺摄取(FTU),8 例(4%)为弥漫性甲状腺摄取(DTU),10 例(5%)为混合摄取(FTU+DTU),共 20 个活跃的甲状腺结节。EU-TIRADS 分类与 PET 参数之间没有相关性。一个高度 18 F-氟胆碱活性的甲状腺结节和一个等活性的甲状腺结节在最终组织学中被证实为甲状腺癌;50%的 DTU 患者患有桥本甲状腺炎。
在 13%的患者中观察到甲状腺中偶然出现的 18 F-氟胆碱摄取。正如 18 F-FDG 所报道的,局灶性 18 F-氟胆碱摄取可能代表甲状腺癌,应通过超声进行评估,如果需要,还应进行细针抽吸细胞学检查。弥漫性 18 F-氟胆碱摄取最可能代表多结节性甲状腺肿或桥本甲状腺炎。